Literature DB >> 24451958

Current status of pediatric kidney transplantation in China: data analysis of Chinese Scientific Registry of Kidney Transplantation.

Longshan Liu1, Huanxi Zhang1, Qian Fu1, Liping Chen1, Chuanhou Sun1, Yunyi Xiong1, Bingyi Shi1, Changxi Wang2.   

Abstract

BACKGROUND: Kidney transplantation (KTx) is the primary therapy for children with renal failure. Unlike KTx in adult patients, it is commonly agreed that pediatric KTx in China is far behind that of America. There has been no systematic analysis of Chinese pediatric KTx reported. This study aimed to demonstrate the current status of pediatric KTx in China.
METHODS: Registry data of pediatric KTx (1983-2012) from Chinese Scientific Registry of Kidney Transplantation (CSRKT) were retrospectively analyzed.
RESULTS: There were 851 pediatric KTx from 102 transplant units. The recipients were (15.4±2.5) years of age, 93.9% of who were over 10 years old. Chronic glomerulonephritis and pyelonephritis accounted for 75.6% of recognized primary diseases. Allografts were from deceased donors (72.2%) or living donation (27.7%). The patient survival for 1, 3, 5, and 10 years was 96.9%, 94.2%, 92.3%, and 92.3% and the graft survival was 94.6%, 91.4%, 86.3%, and 79.2%, respectively. The majority of post-transplant complications were acute rejection and infections. Annual transplant reached the peak in 2008 (n = 114), and decreased sharply in 2006 (n = 41) and 2010 (n = 57). The percentage of pediatric KTx in total KTx was highest in 2007 (1.95%) and decreased to trough level in 2010 (1.0%). Living donation increased by 32.5-folds from 2004 to 2008 and then decreased by 86.6% till 2010. The percentage of living donation in pediatric or total KTx dynamically changed in a similar manner, while living donation ratio in pediatric KTx was much higher.
CONCLUSIONS: Kidney transplant can provide long-term benefits to pediatric recipients. Rejection and infections are worthy of concern during follow-up. Pediatric kidney transplant in China is very much lagging behind that in developed countries. Living donation played an important role in its development in the past decades. New strategies for implementation are encouraged to increase the priority of uremic children in organ allocation so as to promote its progress in China.

Entities:  

Mesh:

Year:  2014        PMID: 24451958

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  5 in total

1.  Survival after Kidney Transplantation during Childhood and Adolescence.

Authors:  Anna Francis; David W Johnson; Anette Melk; Bethany J Foster; Katrina Blazek; Jonathan C Craig; Germaine Wong
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-19       Impact factor: 8.237

2.  The Long-term Outcome of Pediatric Kidney Transplantation in Iran: Results of a 25-year Single-Center Cohort Study.

Authors:  G Naderi; A Latif; S Karimi; F Tabassomi; S T Esfahani
Journal:  Int J Organ Transplant Med       Date:  2017-05-01

3.  Emphysematous Pyelonephritis Treated with Vacuum Sealing Drainage.

Authors:  Hai-Dong Wang; Xiao-Fei Zhu; Xiao Xu; Gui-Zhong Li; Ning Liu; Feng He; Li-Bo Man
Journal:  Chin Med J (Engl)       Date:  2017-01-20       Impact factor: 2.628

4.  Transplantation of a single kidney from pediatric donors less than 10 kg to children with poor access to transplantation: a two-year outcome analysis.

Authors:  Xiaojun Su; Wenjun Shang; Longshan Liu; Jun Li; Qian Fu; Yonghua Feng; Huanxi Zhang; Ronghai Deng; Chenglin Wu; Zhigang Wang; Xinlu Pang; Björn Nashan; Guiwen Feng; Changxi Wang
Journal:  BMC Nephrol       Date:  2020-07-02       Impact factor: 2.388

5.  Pediatric kidney transplantation in China: an analysis from the IPNA Global Kidney Replacement Therapy Registry.

Authors:  Qian Shen; Xiaoyan Fang; Xinyue Man; Yihui Zhai; Longshan Liu; Changxi Wang; Wenjun Shang; Guiwen Feng; Lei Zhang; Li Zeng; Youhua Zhu; Jing Chen; Jia Rao; Bradley A Warady; Franz Schaefer; Hong Xu
Journal:  Pediatr Nephrol       Date:  2020-09-15       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.